Abstract: The present disclosure provides compositions and methods for reducing inflammation to improve or maintain mental health or physical health in an individual. In some aspects, the compositions include at least one 5HT2A agonist and at least one TRP agonist, wherein the therapeutically effective amount of the 5HT2A agonist is between about 1 ?g and about 300 mg and the therapeutically effective amount of the at least one TRP receptor agonist is between about 0.01 mg and about 300 mg. The compositions may be formulated for any suitable ingestion mode, including gastrointestinal, transmucosal and parenteral.

Abstract: The present invention provides cannabis lines, extracts and methods for the treatment of inflammatory skin disorders such as psoriasis, eczema, melanoma skin cancer, and others. The method includes generation of unique lines, whole plant extract preparation, treating human 3D skin tissues and disease models with extracts in amount sufficient to modulate gene expression in the skin tissues. The modulation of gene expression then results in a reduction of the disease state-associated changes or aspects thereof in the treated skin tissues.

Abstract: The present invention provides new unique cannabis lines, extracts and methods for their use in anti-inflammatory therapies and modalities. The method includes generation of unique lines, whole plant extract preparation, treating normal human 3D tissues with UV to induce inflammation, and then with extracts in amount sufficient to profoundly down-regulate inflammation and molecular pathways involved in rheumatoid arthritis (RA), irritable bowel disease (IBD) and other auto-inflammatory disorders. The modulation of these pathways is a key to treatment success in RA, IBD and the other auto-inflammatory disorders.

Abstract: The present invention provides new Cannabis lines, extracts and methods for skin rejuvenation and healing and protection against harmful environmental factors such as UV rays and other damaging agents. The method includes generation of unique lines, whole plant extract preparation, exposing human 3D skin tissues to UV and treating human 3D skin tissues with extracts in amount sufficient to modulate gene expression in the skin tissues before and after UV exposure. The modulation of gene expression then results in a reduction of the disease state-associated changes or aspects thereof in the cannabis-treated skin tissues.

Abstract: The present invention provides new unique Cannabis lines, extracts and methods for their use in anti-cancer therapies and modalities. The method includes generation of unique lines, whole plant extract preparation, treating cancer cells and normal cells with extracts in amounts sufficient to kill cancer cells while sparing normal ones. The modulation of cell proliferation, growth and death results in efficient elimination of cancer cells.